# STREAMER : STent Restenosis And MEdicaments Release

> **NCT02835586** · PHASE3 · COMPLETED · sponsor: **Hospices Civils de Lyon** · enrollment: 15 (actual)

## Conditions studied

- Critical Ischemia

## Interventions

- **DRUG:** Paclitaxel

## Key facts

- **NCT ID:** NCT02835586
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05
- **Primary completion:** 2015-11
- **Final completion:** 2015-11
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2016-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02835586

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02835586, "STREAMER : STent Restenosis And MEdicaments Release". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02835586. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
